Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000899243-22-035477)

Filing Details

Accession Number:
0000899243-22-035477
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-10 08:30:11
Reporting Period:
2022-11-08
Accepted Time:
2022-11-10 08:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492422 Apellis Pharmaceuticals Inc. APLS Pharmaceutical Preparations (2834) 271537290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657720 Pascal Deschatelets C/O Apellis Pharmaceuticals, Inc.
100 Fifth Avenue.
Waltham MA 02451		 Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-08 18,500 $2.67 975,780 No 4 M Direct
Common Stock Disposition 2022-11-08 12,000 $46.47 963,780 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-11-08 18,500 $0.00 18,500 $2.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
220,994 2023-12-05 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2022.
  2. This stock option was granted on 12/5/2013 and is fully vested.